Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E E Sugg

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Peptide and Protein Research|September 1, 1987
Analogs of oxytocin containing a modified peptide bondM Lebl, E E Sugg, G van Binst, et al.
International Journal of Peptide and Protein Research|June 1, 1988
Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residueE E Sugg, M Serra, J E Shook, et al.
The Journal of Biological Chemistry|January 5, 1991
Allele-specific activation of genetically engineered receptorsC D Strader, T Gaffney, E E Sugg, et al.
Life Sciences|November 3, 1986
Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33E E Sugg, J E Shook, M Serra, et al.
Journal of Medicinal Chemistry|January 6, 1995
CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623)E E Sugg, M J Kimery, J M Ding, et al.
Biochemistry|March 9, 1993
Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channelsK M Giangiacomo, E E Sugg, M Garcia-Calvo, et al.
The Biochemical Journal|January 15, 1992
Purification and characterization by fast-atom-bombardment mass spectrometry of the polymorphonuclear-leucocyte-elastase-generated A alpha (1-21) fragment of fibrinogen from human blood after incubation with calcium ionophore A23187R S Dewey, J M Liesch, H R Williams, et al.
Vaccine|April 1, 1994
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogensA J Conley, P Conard, S Bondy, et al.
Journal of Medicinal Chemistry|August 18, 1995
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligandsM Dezube, E E Sugg, L S Birkemo, et al.
Journal of Medicinal Chemistry|July 5, 1996
3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agentsB R Henke, T M Willson, E E Sugg, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Peptide and Protein Research|September 1, 1987
Analogs of oxytocin containing a modified peptide bondM Lebl, E E Sugg, G van Binst, et al.
International Journal of Peptide and Protein Research|June 1, 1988
Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residueE E Sugg, M Serra, J E Shook, et al.
The Journal of Biological Chemistry|January 5, 1991
Allele-specific activation of genetically engineered receptorsC D Strader, T Gaffney, E E Sugg, et al.
Life Sciences|November 3, 1986
Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33E E Sugg, J E Shook, M Serra, et al.
Journal of Medicinal Chemistry|January 6, 1995
CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623)E E Sugg, M J Kimery, J M Ding, et al.
Biochemistry|March 9, 1993
Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channelsK M Giangiacomo, E E Sugg, M Garcia-Calvo, et al.
The Biochemical Journal|January 15, 1992
Purification and characterization by fast-atom-bombardment mass spectrometry of the polymorphonuclear-leucocyte-elastase-generated A alpha (1-21) fragment of fibrinogen from human blood after incubation with calcium ionophore A23187R S Dewey, J M Liesch, H R Williams, et al.
Vaccine|April 1, 1994
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogensA J Conley, P Conard, S Bondy, et al.
Journal of Medicinal Chemistry|August 18, 1995
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligandsM Dezube, E E Sugg, L S Birkemo, et al.
Journal of Medicinal Chemistry|July 5, 1996
3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agentsB R Henke, T M Willson, E E Sugg, et al.
Pageof 3